Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive changes to the study details or layout were detected.SummaryDifference0.0%

- Check13 days agoChange DetectedPublications section wording updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision line now shows Revision: v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding status notice on the page has been removed.SummaryDifference0.3%

- Check35 days agoChange DetectedThe page updates are minor editorial changes with no substantive alterations to the study design, endpoints, or enrollment data.SummaryDifference0.3%

- Check64 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check71 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.